Di Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Di Lu has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Oguz Kanca
Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, TX, USA; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital (TCH), Houston, TX, USA
2 shared publications- Paul C. Marcogliese
Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences University of Manitoba Winnipeg Manitoba Canada
2 shared publications Undiagnosed Diseases Network
2 shared publicationsAlex J Ho
Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX, USA; Advanced Technology Core for Macromolecular X-ray Crystallography, Baylor College of Medicine, Houston, TX, USA
1 shared publicationAngelina Gaspero
Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, TX, USA
1 shared publication- Audrey E. Christiansen
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, USA
1 shared publication
Latest Publications
- Open Access
- 9 July 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (9) , 102648
Uncovering Phenotypic Expansion in AXIN2-Related Disorders through Precision Animal Modeling
- 9 July 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (9) , 102648
Open AccessUncovering Phenotypic Expansion in AXIN2-Related Disorders through Precision Animal Modeling
- Open Access
- 21 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (3) , eabl5613
Loss of IRF2BPL impairs neuronal maintenance through excess Wnt signaling
De novo truncations in Interferon Regulatory Factor 2 Binding Protein Like ( IRF2BPL ) lead to severe childhood-onset neurodegenerative disorders. To determine how loss of IRF2BPL causes neural dysfunction, we examined its function in Drosophila and zebrafish. Overexpression of either IRF2BPL or Pits , the Drosophila ortholog, represses Wnt transcription in flies. In contrast, neuronal depletion of Pits leads to increased wingless ( wg ) levels in the brain and is associated with axonal loss, whereas inhibition of Wg signaling is neuroprotective. Moreover, increased neuronal expression of wg in flies is sufficient to cause age-dependent axonal loss, similar to reduction of Pits. Loss of irf2bpl in zebrafish also causes neurological defects with an associated increase in wnt1 transcription and downstream signaling. WNT1 is also increased in patient-derived astrocytes, and pharmacological inhibition of Wnt suppresses the neurological phenotypes. Last, IRF2BPL and the Wnt antagonist, CKIα, physically and genetically interact, showing that IRF2BPL and CkIα antagonize Wnt transcription and signaling.
- 21 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (3) , eabl5613
Open AccessLoss of IRF2BPL impairs neuronal maintenance through excess Wnt signaling
De novo truncations in Interferon Regulatory Factor 2 Binding Protein Like ( IRF2BPL ) lead to severe childhood-onset neurodegenerative disorders. To determine how loss of IRF2BPL causes neural dysfunction, we examined its function in Drosophila and zebrafish. Overexpression of either IRF2BPL or Pits , the Drosophila ortholog, represses Wnt transcription in flies. In contrast, neuronal depletion of Pits leads to increased wingless ( wg ) levels in the brain and is associated with axonal loss, whereas inhibition of Wg signaling is neuroprotective. Moreover, increased neuronal expression of wg in flies is sufficient to cause age-dependent axonal loss, similar to reduction of Pits. Loss of irf2bpl in zebrafish also causes neurological defects with an associated increase in wnt1 transcription and downstream signaling. WNT1 is also increased in patient-derived astrocytes, and pharmacological inhibition of Wnt suppresses the neurological phenotypes. Last, IRF2BPL and the Wnt antagonist, CKIα, physically and genetically interact, showing that IRF2BPL and CkIα antagonize Wnt transcription and signaling.